The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 23, 2015

Filed:

Dec. 17, 2012
Applicant:

Merck Sharp & Dohme Corp, Rahway, NJ (US);

Inventors:

Yao Ma, Lexington, MA (US);

Manami Shizuka, Lexington, MA (US);

Timothy J. Guzi, Sudbury, MA (US);

Yuan Liu, Belmont, MA (US);

Yuan Tian, Newton, MA (US);

Brian R. Lahue, Millbury, MA (US);

Craig R. Gibeau, Natick, MA (US);

Gerald W. Shipps, Jr., Stoneham, MA (US);

Yaolin Wang, Short Hills, NJ (US);

Stephane L. Bogen, Somerset, NJ (US);

Latha G. Nair, Edison, NJ (US);

Weidong Pan, Somerset, NJ (US);

Mark A. McCoy, Basking Ridge, NJ (US);

Matthew E. Voss, Ville de West, SG;

Margarita Kirova-Snover, Troy, NY (US);

W. Bent Clayton, Wynantskill, NY (US);

Assignee:

Merck Sharp & Dohme Corp., Rahway, NJ (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 409/14 (2006.01); C07D 495/04 (2006.01); A61K 31/497 (2006.01);
U.S. Cl.
CPC ...
C07D 495/04 (2013.01); C07D 409/14 (2013.01);
Abstract

The present invention provides a compound of Formula I (The formula should be inserted here) as described herein or a pharmaceutically acceptable salt or solvate thereof. The representative compounds are useful as inhibitors of the HDM2 protein. Also disclosed are pharmaceutical compositions comprising the above compounds and potential methods of treating cancer using the same.


Find Patent Forward Citations

Loading…